RadNet Inc. (RDNT) Insider Norman R. Hames Sells 5,000 Shares of Stock

RadNet Inc. (NASDAQ:RDNT) insider Norman R. Hames sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $10.00, for a total value of $50,000.00. Following the completion of the sale, the insider now owns 407,257 shares in the company, valued at $4,072,570. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of RadNet Inc. (NASDAQ:RDNT) opened at $9.90 on Tuesday. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market capitalization of $481.00, a price-to-earnings ratio of 33.67, a PEG ratio of 3.39 and a beta of 0.82. RadNet Inc. has a 1-year low of $5.25 and a 1-year high of $11.90.

RadNet (NASDAQ:RDNT) last announced its earnings results on Thursday, November 9th. The medical research company reported $0.12 EPS for the quarter, hitting the consensus estimate of $0.12. The company had revenue of $227.60 million for the quarter, compared to analysts’ expectations of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The business’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.11 earnings per share. research analysts expect that RadNet Inc. will post 0.35 EPS for the current fiscal year.

A number of analysts have weighed in on the company. Zacks Investment Research cut RadNet from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. TheStreet upgraded RadNet from a “c” rating to a “b-” rating in a report on Thursday, August 24th. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, Jefferies Group upgraded RadNet from a “hold” rating to a “buy” rating and increased their target price for the stock from $7.00 to $12.00 in a report on Tuesday, August 22nd.

Several hedge funds have recently made changes to their positions in RDNT. American International Group Inc. grew its holdings in shares of RadNet by 7.0% during the first quarter. American International Group Inc. now owns 22,857 shares of the medical research company’s stock worth $135,000 after purchasing an additional 1,500 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of RadNet by 2.5% during the first quarter. Vanguard Group Inc. now owns 1,233,623 shares of the medical research company’s stock worth $7,278,000 after purchasing an additional 30,054 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of RadNet by 6.6% during the first quarter. Geode Capital Management LLC now owns 274,192 shares of the medical research company’s stock worth $1,617,000 after purchasing an additional 16,924 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of RadNet by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,419,656 shares of the medical research company’s stock worth $8,376,000 after purchasing an additional 43,960 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in shares of RadNet by 5.9% during the first quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock worth $157,000 after purchasing an additional 1,477 shares during the last quarter. Institutional investors own 53.24% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “RadNet Inc. (RDNT) Insider Norman R. Hames Sells 5,000 Shares of Stock” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2017/12/05/radnet-inc-rdnt-insider-norman-r-hames-sells-5000-shares-of-stock.html.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply